No matches

ADVENT is a global medical education non-promotional program by Sanofi and Regeneron. This website is intended only for duly authenticated healthcare professionals in Algeria, Argentina, Australia, Austria, Bahrain, Belgium, Brazil, Bulgaria, Canada, Chile, China, Colombia, Costa Rica, Croatia, Czech Republic, Denmark, Dominican Republic, Ecuador, Egypt, Estonia, Finland, France, Germany, Greece, Guatemala, Hong Kong, Hungary, Iceland, India, Israel, Italy, Japan, Kuwait, Latvia, Lebanon, Lithuania, Macau, Malaysia, Norway, Oman, Panama, Peru, Poland, Portugal, Qatar, Romania, Saudi Arabia, Singapore, Slovenia, South Africa, South Korea, Spain, Sudan, Sweden, Switzerland, Taiwan, Thailand, The Netherlands, Turkey, United Arab Emirates, or the United States of America.

For healthcare professionals in Algeria: Please read the additional Terms of Use.

Sanofi and Regeneron are global leaders in pharmaceutical development, each with a long history of supporting frontline physicians to improve human health and reduce the burden of disease. Driven by the same commitment to patients and their families, Sanofi and Regeneron have partnered to take on type 2 inflammation and the range of chronic conditions in which excessive inflammation plays a role.

Country/region: PolandChange country/region

Rhinology

Stella Lee

Chief of Rhinology at Brigham and Women’s Hospital | Harvard Medical School, Boston, United States

Biography

Stella Lee, MD, is a fellowship-trained rhinologist and Chief of Rhinology at Brigham and Women’s Hospital/Harvard Medical School. She is a clinician scientist developing novel management strategies for the care of patients with inflammatory upper airway disease as well as a leader in the development of therapeutics for airway inflammation.

Before joining the Brigham faculty, Dr. Lee served as the Division Chief for Sinonasal Disorders and Allergy in the Department of Otolaryngology at the University of Pittsburgh Medical Center for ten years where she led several of the pivotal trials in biologic therapies for CRS. Her research interests include defining inflammatory endotypes of chronic rhinosinusitis, the impact of environmental pollution on airway inflammation, and the development of basic to translational approaches to solving chronic inflammation. She is a leader in the investigation of targeted therapeutics and the creation of new paradigms of how we conceptualize and treat upper airway disorders.